Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages

Pharmaceutical Research

Volumn 27, Issue 8, 2010, Pages 1584-1596

  Yu, Wangyang ^a   Liu, Chunxi ^a   Liu, Yu ^a   Zhang, Na ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

active targeting; cationic solid lipid nanoparticles; gene delivery; mannan based PE grafted ligand; surface modification

Indexed keywords

CATION; DNA; LIPOFECTAMINE; MANNAN; NAKED DNA; PHOSPHATIDYLETHANOLAMINE; SOLID LIPID NANOPARTICLE; CONCANAVALIN A; LIGAND; LIPID; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; DNA MODIFICATION; DRUG DOSAGE FORM COMPARISON; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE THERAPY; METABOLISM; MOUSE; PROCEDURES; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CONCANAVALIN A; DRUG DELIVERY SYSTEMS; GENE THERAPY; LIGANDS; LIPIDS; MACROPHAGES, ALVEOLAR; MALE; MANNANS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; NANOPARTICLES; PHOSPHATIDYLETHANOLAMINES; RATS; RATS, WISTAR; GENETIC THERAPY;

EID: 77955434240     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0149-z     Document Type: Article

References (40)

1. A Jemal MJ Thun LA Ries HL Howe HK Weir MM Center E Ward XC Wu C Eheman R Anderson UA Ajani B Kohler BK Edwards 2008 Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control J Natl Cancer Inst 100 1672 1694 10.1093/jnci/djn389 19033571
2. CL Tseng SY Wu WH Wang CL Peng FH Lin CC Lin TH Young MJ Shieh 2008 Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer Biomaterials 29 3014 3022 10.1016/j.biomaterials.2008.03.033 18436301
3. W Wijagkanalan S Kawakami M Takenaga R Igarashi F Yamashita M Hashida 2008 Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats J Control Release 125 121 130 10.1016/j.jconrel.2007.10.011 18037185 (Pubitemid 350299608)
4. B Murer 2008 Targeted therapy in non-small cell lung cancer a commentary Arch Pathol Lab Med 132 1573 1575 18834213
5. M Morille C Passirani A Vonarbourg A Clavreul JP Benoit 2008 Progress in developing cationic vectors for non-viral systemic gene therapy against cancer Biomaterials 29 3477 3496 10.1016/j.biomaterials.2008.04.036 18499247
6. A Rolland 2005 Gene medicines: the end of the beginning? Adv Drug Deliv Rev 57 669 673 10.1016/j.addr.2005.01.002 15757753 (Pubitemid 40332595)
7. XB Zhao RJ Lee 2004 Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor Adv Drug Deliv Rev 56 1193 1204 10.1016/j.addr.2004.01.005 15094215 (Pubitemid 38496515)
8. MK Lee SJ Lim CK Kim 2007 Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles Biomaterials 28 2137 2146 10.1016/j.biomaterials.2007.01.014 17257668 (Pubitemid 46198929)
9. HW Zhang JZ Bei SG Wang 2009 Multi-morphological biodegradable PLGE nanoparticles and their drug release behavior Biomaterials 30 100 107 10.1016/j.biomaterials.2008.09.016 18848724
10. E Karathanasis L Chan SR Balusu CJ D'Orsi AV Annapragada I Sechopoulos RV Bellamkonda 2008 Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy Biomaterials 29 4815 4822 10.1016/j.biomaterials.2008.08.036 18814908
11. W Yu C Liu J Ye W Zou N Zhang W Xu 2009 Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery Nanotechnology 20 215102 10.1088/0957-4484/20/21/215102 19423923
12. J Ye A Wang C Liu Z Chen N Zhang 2008 Anionic solid lipid nanoparticles supported on protamine/DNA complexes Nanotechnology 19 285708 10.1088/0957-4484/19/28/285708 (Pubitemid 351813759)
13. W Zou C Liu Z Chen N Zhang 2009 Studies on bioadhesive PLGA nanoparticles: a promising gene delivery system for efficient gene therapy to lung cancer Int J Pharm 370 187 195 10.1016/j.ijpharm.2008.11.016 19073241
14. W Yu N Zhang 2009 Surface modification of nanocarriers for cancer therapy Curr Nanosci 5 123 134 10.2174/157341309788185370
15. VP Torchilin 2007 Targeted pharmaceutical nanocarriers for cancer therapy and imaging AAPS J 9 E128 E147 10.1208/aapsj0902015 17614355
16. LE van Vlerken TK Vyas MM Amiji 2007 Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery Pharm Res 24 1405 1414 10.1007/s11095-007-9284-6 17393074 (Pubitemid 46988224)
17. A Beduneau P Saulnier JP Benoit 2007 Active targeting of brain tumors using nanocarriers Biomaterials 28 4947 4967 10.1016/j.biomaterials.2007.06.011 17716726 (Pubitemid 47362345)
18. W Wijagkanalan S Kawakami M Takenaga R Igarashi F Yamashita M Hashida 2008 Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats J Control Release 125 121 130 10.1016/j.jconrel.2007.10.011 18037185 (Pubitemid 350299608)
19. S Kawakami Y Higuchi M Hashida 2008 Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide J Pharm Sci 97 726 745 10.1002/jps.21024 17823947 (Pubitemid 351293877)
20. A Mantovani T Schioppa C Porta P Allavena A Sica 2006 Role of tumor-associated macrophages in tumor progression and invasion Cancer Metastasis Rev 25 315 322 10.1007/s10555-006-9001-7 16967326 (Pubitemid 44922352)
21. A Sica T Schioppa A Mantovani P Allavena 2006 Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 717 727 10.1016/j.ejca.2006.01.003 16520032
22. RA Ezekowitz DJ Williams H Koziel MY Armstrong A Warner FF Richards RM Rose 1991 Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor Nature 351 155 158 10.1038/351155a0 1903183
23. ZR Cui CH Hsu RJ Mumper 2003 Physical characterization and macrophage cell uptake of mannan-coated nanoparticles Drug Dev Ind Pharm 29 689 700 10.1081/DDC-120021318 12889787 (Pubitemid 36835162)
24. ZG Cui SJ Han L Huang 2004 Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor Pharm Res 21 1018 1025 10.1023/B:PHAM.0000029292.66792.4f 15212168 (Pubitemid 38870153)
25. Y Hattori S Kawakami S Suzuki F Yamashita M Hashida 2004 Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice Biochem Biophys Res Commun 317 992 999 10.1016/j.bbrc.2004.03.141 15094367 (Pubitemid 38496408)
26. A Kaur S Jain AK Tiwary 2008 Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation Acta Pharm 58 61 74 10.2478/v10007-007-0045-1 18337208 (Pubitemid 351419158)
27. S Azarmi WH Roa R Loebenberg 2008 Targeted delivery of nanoparticles for the treatment of lung diseases Adv Drug Deliv Rev 60 863 875 10.1016/j.addr.2007.11.006 18308418
28. W Yu N Zhang C Li 2009 Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery Curr Pharm Des 15 3826 3836 10.2174/138161209789649547 19925431
29. S Kawakami J Wong A Sato Y Hattori F Yamashita M Hashida 2000 Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice Biochim Biophys Acta Gen Subj 1524 258 265 10.1016/S0304-4165(00)00163-X
30. L Yang L Cheng Y Wei L Tian 2003 Synthesis of N-[2- (cholesteryloxycarbonylamino) ethyl] carbamoylmethylated mannan Sichuan Da Xue Xue Bao Yi Xue Ban 34 730 732 14619595
31. SP Vyas V Sihorkar S Jain 2007 Mannosylated liposomes for bio-film targeting Int J Pharm 330 6 13 10.1016/j.ijpharm.2006.08.034 16997519 (Pubitemid 46097355)
32. Z Cui RJ Mumper 2002 Topical immunization using nanoengineered genetic vaccines J Control Release 81 173 184 10.1016/S0168-3659(02)00051-2 11992690 (Pubitemid 34454859)
33. K Tabatt M Sameti C Olbrich RH Muller CM Lehr 2004 Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer Eur J Pharm Biopharm 57 155 162 10.1016/j.ejpb.2003.10.015 15018970 (Pubitemid 38283690)
34. C Managit S Kawakami F Yamashita M Hashida 2005 Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes J Pharm Sci 94 2266 2275 10.1002/jps.20443 16136555 (Pubitemid 41665286)
35. W Yeeprae S Kawakami F Yamashita M Hashida 2006 Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages J Control Release 114 193 201 10.1016/j.jconrel.2006.04.010 16876282 (Pubitemid 44291840)
36. M Monsigny C Quetard S Bourgerie D Delay C Pichon P Midoux R Mayer AC Roche 1998 Glycotargeting: the preparation of glyco-amino acids and derivatives from unprotected reducing sugars Biochimie 80 99 108 10.1016/S0300-9084(98) 80016-3 9587667 (Pubitemid 28185048)
37. A Barre Y Bourne EJ Van Damme WJ Peumans P Rouge 2001 Mannose-binding plant lectins: different structural scaffolds for a common sugar-recognition process Biochimie 83 645 651 10.1016/S0300-9084(01)01315-3 11522393 (Pubitemid 32821228)
38. K Shibata Y Kudo M Tsunoda M Hosokawa Y Sakai M Kotani Y Aizawa 2007 Magnetometric evaluation of the effects of man-made mineral fibers on the function of macrophages using the macrophage cell line RAW 264.7 Ind Health 45 426 436 10.2486/indhealth.45.426 17634692 (Pubitemid 47217205)
39. AV Kabanov 2006 Polymer genomics: an insight into pharmacology and toxicology of nanomedicines Adv Drug Deliv Rev 58 1597 1621 10.1016/j.addr.2006. 09.019 17126450 (Pubitemid 44841931)
40. KR Vega-Villa JK Takemoto JA Yanez CM Remsberg ML Forrest NM Davies 2008 Clinical toxicities of nanocarrier systems Adv Drug Deliv Rev 60 929 938 10.1016/j.addr.2007.11.007 18313790